Penicillin tolerance in Arcanobacterium haemolyticum

The Journal of Infectious Diseases
M NymanM Thore

Abstract

It was previously found that Arcanobacterium haemolyticum, which can cause tonsillitis with exanthema, is not eradicated from the pharynx by administration of phenoxymethylpenicillin, despite minimum inhibitory concentration values of 0.015-1.0 micrograms/ml. Therefore, recent clinical isolates were studied for penicillin tolerance by using a disk diffusion screening test and a pour plate assay. Macrobroth dilution minimum inhibitory and bactericidal concentrations and antibiotic kill kinetics were determined for 4 isolates. Tolerance was present in 38 of 40 clinical isolates with the disk diffusion assay. With the pour plate assay all 40 isolates were tolerant, 34 of them highly tolerant. The presence of the tolerant phenotype was confirmed by macrobroth dilution assays. It is concluded that A. haemolyticum is often penicillin-tolerant, suggesting that phenoxymethylpenicillin administration would be ineffective in eradicating A. haemolyticum from the pharynx.

Citations

Dec 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J I AlósJ L Gómez-Garcés
Jun 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E RitterH Finger
Oct 30, 2009·The New England Journal of Medicine·Charles R TaylorLyn M Duncan
Jan 1, 1994·Antimicrobial Agents and Chemotherapy·P CarlsonO V Renkonen
May 17, 2011·Annals of Clinical Microbiology and Antimicrobials·Vanessa WongShiu Soo
Jan 24, 1998·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·S ArikanA Günalp
Feb 13, 2004·Mayo Clinic Proceedings·Matthew W Martinez, Randall S Edson
Jan 21, 2009·Periodontology 2000·Anna Stjernquist-Desatnik, Arne Orrling
Mar 11, 2006·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·M A Cabañero PisaR Baraibar Castelló
Oct 12, 2010·New Zealand Veterinary Journal·J B Bancroft-HuntJ S Munday
Jan 1, 1994·Scandinavian Journal of Infectious Diseases·P CarlsonS Kontiainen
Nov 24, 2007·Journal of Medical Microbiology·I H M van LooM F Peeters
Sep 25, 2008·The Annals of Pharmacotherapy·Bridgette L TherriaultRalph H Raasch
Nov 7, 2012·Ophthalmic Plastic and Reconstructive Surgery·Nicholas A Ramey, Cat N Burkat
Oct 31, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R L SkovT Ejlertsen
May 1, 2017·Infectious Diseases in Clinical Practice : IDCP·Nicolás Cortés-PenfieldHana El Sahly
Jan 1, 1995·Scandinavian Journal of Infectious Diseases·P CarlsonR Visakorpi
Jan 1, 1997·Clinical Microbiology Reviews·G FunkeK A Bernard
Jun 1, 1997·Mayo Clinic Proceedings·E F BerbariJ M Steckelberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Antimicrobial Agents and Chemotherapy
P CarlsonO V Renkonen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
A MackenzieF Diaz-Mitoma
© 2021 Meta ULC. All rights reserved